KLF2 and Miyoshi myopathy: Oncogene, LDLRAD4, which was highly expressed in multiple cancers (e.g., hepatic cancer, breast cancer and colon cancer) [29], and KLF2, an essential transcriptional factor for MM cell survival [18], were also downregulated in all treated cells.